The fate of chemoresistance in triple negative breast cancer (TNBC)

BACKGROUND: Treatment options for women presenting with triple negative breast cancer (TNBC) are limited due to the lack of a therapeutic target and as a result, are managed with standard chemotherapy such as paclitaxel (Taxol®). Following chemotherapy, the ideal tumour response is apoptotic cell de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BBA Clin
Hauptverfasser: O’Reilly, Elma A., Gubbins, Luke, Sharma, Shiva, Tully, Riona, Guang, Matthew Ho Zhing, Weiner-Gorzel, Karolina, McCaffrey, John, Harrison, Michele, Furlong, Fiona, Kell, Malcolm, McCann, Amanda
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2015
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4661576/
https://ncbi.nlm.nih.gov/pubmed/26676166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbacli.2015.03.003
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge